EUVIMEDEUVIMED entdecken
CrossrefInfokarte

From synthesis to process by overcoming enzyme limitations: Design of an asymmetric reductive amination route to L-β-methylphenylalanine at high substrate loading catalyzed by glutamate dehydrogenase

Mattis Rottmann, Haruka Homma, Ulf Hanefeld, Harald Gröger

Synlett · 2026-11-12

DOI: 10.1055/a-3002-2649 ↗
AbstractBibliografische Angaben

Abstract

Enantiomerically pure non-canonical α-amino acids gain an increasing interest and are considered as valuable building blocks in drug discovery, e.g., when generating cyclic peptides. A compound class of specific interest are the diastereoisomers of L-β-methylphenylalanine. Addressing this demand, we explored the potential of amino acid dehydrogenases for their synthesis through reductive amination starting from a racemic α-keto acid. In spite of severe deactivation and substrate as well as product inhibition effects resulting in a low conversion below 10% under standard conditions, we could overcome such limitations through process engineering leading to 80% conversion when operating at a technically relevant substrate loading of 40 g/L (200 mM). In addition, we were able to demonstrate that this lab scale synthesis is scalable by a factor of 10, leading to a conversion of 63%, yield of 49% (340 mg), >99% ee, and 6% de.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →